Broad kinase inhibition mitigates early neuronal dysfunction in tauopathy

We treated early stage tau transgenic mice with a multi-target kinase inhibitor. Drug treatment significantly ameliorated brain atrophy and cognitive function as determined by behavioral testing and a sensitive imaging technique called manganese-enhanced magnetic resonance imaging (MEMRI) with quantitative R1 mapping. Surprisingly, these benefits occurred despite unchanged hyperphosphorylated tau levels. We identified a cluster of […]